Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3674337017 | Dinoprostone 3 mg vaginal tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3674338010 | Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
46714501000001117 | Dinoprostone 3mg pessaries | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Is a | Product containing dinoprostone in vaginal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has active ingredient | Prostaglandin PGE>2< | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has active ingredient | Prostaglandin E>1< | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has active ingredient | Dinoprostone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has active ingredient | Posterior pituitary hormone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has active ingredient | Alprostadil | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has manufactured dose form | Vaginal dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has manufactured dose form | Conventional release vaginal tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has basis of strength substance | Dinoprostone | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has presentation strength numerator value | 3 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has precise active ingredient | Dinoprostone | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Is a | Product containing only dinoprostone in vaginal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Plays role | Oxytocic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Is a | Dinoprostone | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has manufactured dose form | Vaginal dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has manufactured dose form | Conventional release vaginal tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has active ingredient | Dinoprostone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | pessary.vaginal ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Vaginal route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has manufactured dose form | Pessary | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has manufactured dose form | Conventional release vaginal tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has manufactured dose form | Conventional release vaginal tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has manufactured dose form | Pessary | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has manufactured dose form | Pessary | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has specific active ingredient | Dinoprostone | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has dispensed dose form | Pessary | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Has manufactured dose form | Pessary | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Dinoprostone 3mg vaginal tablet - product | Is a | False | Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Inferred relationship | Existential restriction modifier | |
Prostin E2 3mg vaginal tablets (Pfizer Ltd) | Is a | True | Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Inferred relationship | Existential restriction modifier | |
Dinoprostone 3mg vaginal tablets 8 pessary | Is pack of | False | Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Inferred relationship | Existential restriction modifier | |
Dinoprostone 3mg vaginal tablets 8 pessary | Has VMP | True | Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets